Literature DB >> 17188884

Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations.

Hartmuth B Bittner1, Christian Binner, Sven Lehmann, Thomas Kuntze, Ardawan Rastan, Friedrich W Mohr.   

Abstract

OBJECTIVE: Cardiopulmonary bypass (CPB) support is required in some lung transplantation (LTX) operations. CPB support and full-dose heparin increases the risks of bleeding and early graft dysfunction. We report our experiences of replacing CPB with heparin-bonded low-dose heparin extracorporeal membrane oxygenation (ECMO) support in LTX surgery.
METHODS: From 2003 to 2005 forty-seven patients were transplanted. Thirty-seven LTX patients were retrospectively evaluated for this study (10 patients were excluded due to heart-lung-, lung-kidney transplantation, LTX with bypass grafting, and ASD closure or emergency CPB support). Extracorporeal circulation support was necessary in 40% of the 37 LTX patients due to severe primary or secondary pulmonary hypertension (P or SPHTN), right heart dysfunction, or hemodynamic instability. There were seven LTX procedures with CPB and eight implantations with ECMO support. CPB (high-dose heparin) and ECMO support (ACT 160-220 s) was always set up through femoral veno-arterial canulation. All patients had limited access thoracotomies without transsection of the sternum. Normothermia was maintained in all patients. CPB patients: PPH 15%, COPD 15%, IPF with mean PAP>40 mmHg 70%. ECMO patients: PPH 13%, COPD 13%, IPF with severe PAP pressure elevation 74%.
RESULTS: In patients undergoing LTX for PPH, the ECMO support was directly extended into the post-operative period. Packed red blood cell (PRBC) transfusion requirements during the operation and the first 24h were 13.25+/-1.6 PRBC units versus 5.1+/-2.8 PRBC units on CBP (p=0.02). Operative time was longer (p=0.11) in the ECMO LTX (451 min+/-76 vs 346+/-140). The increased 90-day mortality rate of the ECMO patients showed a trend toward significance (p=0.056), which was related to infectious complications (3 vs 1 patient). Severe graft ischemia/reperfusion injury occurred in 9% in the CPB versus 13% in the ECMO group. The 1-year survival was significantly reduced in ECMO patients (p=0.004, log-rank test).
CONCLUSIONS: The advantages of femoral canulation rather than conventional central connections in lung transplantation procedures led to an undisturbed operative field. A significantly higher blood product amount was required in ECMO patients, which might lead to increased infection and mortality rates. CPB, obviously, should remain the standard support technique if extracorporeal circulation is required in lung transplantation surgery.

Entities:  

Mesh:

Year:  2006        PMID: 17188884     DOI: 10.1016/j.ejcts.2006.11.050

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  15 in total

Review 1.  Established and potential predictors of blood loss during lung transplant surgery.

Authors:  Pascal Oechslin; Marco P Zalunardo; Ilhan Inci; Martin Schlaepfer; Bastian Grande
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 2.  New horizons of non-emergent use of extracorporeal membranous oxygenator support.

Authors:  George Makdisi; Peter B Makdisi; I-Wen Wang
Journal:  Ann Transl Med       Date:  2016-02

3.  Extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation: a meta-analysis.

Authors:  Dimitrios E Magouliotis; Vasiliki S Tasiopoulou; Alexis A Svokos; Konstantina A Svokos; Dimitris Zacharoulis
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-09-16

Review 4.  Lung volume reduction followed by lung transplantation-considerations on selection criteria and outcome.

Authors:  Alexis Slama; Christian Taube; Markus Kamler; Clemens Aigner
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

5.  Short-term outcomes of cadaveric lung transplantation in ventilator-dependent patients.

Authors:  Hsao-Hsun Hsu; Jin-Shing Chen; Wen-Je Ko; Shu-Chien Huang; Shuenn-Wen Kuo; Pei-Ming Huang; Nai-Hsin Chi; Chin-Chih Chang; Robert J Chen; Yung-Chie Lee
Journal:  Crit Care       Date:  2009-08-06       Impact factor: 9.097

6.  Postoperative cardiac arrest after heart surgery: does extracorporeal perfusion support a paradigm change in management?

Authors:  Edward Gologorsky; Francisco Igor B Macedo; Enisa M Carvalho; Angela Gologorsky; Marco Ricci; Tomas A Salerno
Journal:  Anesthesiol Res Pract       Date:  2010-06-03

7.  Transition to routine use of venoarterial extracorporeal oxygenation during lung transplantation could improve early outcomes.

Authors:  Woo Sik Yu; Hyo Chae Paik; Seok Jin Haam; Chang Young Lee; Kyung Sik Nam; Hee Suk Jung; Young Woo Do; Jee Won Shu; Jin Gu Lee
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 8.  Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation.

Authors:  Mary K Porteous; Joshua M Diamond; Jason D Christie
Journal:  Curr Opin Organ Transplant       Date:  2015-10       Impact factor: 2.640

9.  Predictors of blood loss in lung transplant surgery-a single center retrospective cohort analysis.

Authors:  Bastian Grande; Pascal Oechslin; Martin Schlaepfer; Burkhardt Seifert; Ilhan Inci; Isabelle Opitz; Donat R Spahn; Walter Weder; Marco Zalunardo
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

10.  Respiratory failure after lung transplantation: extra-corporeal membrane oxygenation as a rescue treatment.

Authors:  Paulo Manuel Pêgo-Fernandes; Ludhmila Abrahão Hajjar; Filomena Regina Barbosa Gomes Galas; Marcos Naoyuki Samano; Alexandre Kazantzi Fonseca Ribeiro; Marcelo Park; Rodolfo Soares; Eduardo Osawa; Fabio Biscegli Jatene
Journal:  Clinics (Sao Paulo)       Date:  2012-12       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.